DrugPatentWatch Database Preview
Litigation Details for Takeda Pharmaceutical Company Limited v. Mylan, Inc. (S.D.N.Y. 2012)
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Takeda Pharmaceutical Company Limited v. Mylan, Inc. (S.D.N.Y. 2012)
| Docket | Start Trial | Date Filed | 2012-01-03 |
| Court | District Court, S.D. New York | Date Terminated | 2014-02-26 |
| Cause | 35:271 Patent Infringement | Assigned To | Denise Cote |
| Jury Demand | None | Referred To | Magistrate Judge Ronald L. Ell |
| Parties | ANDRX LABS, LLC; MYLAN PHARMACEUTICALS, INC.; MYLAN, INC.; TAKEDA GLOBAL RESEARCH AND DEVELOPMENT CENTER, INC.; TAKEDA PHARMACEUTICAL COMPANY LIMITED; TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.; WATSON PHARMACEUTICALS, INC. | ||
| Patents | 5,965,584; 6,099,859; 6,166,043; 6,172,090; 6,495,162; 6,866,866; 7,785,627; 7,959,946 | ||
| Attorneys | Adam Phillip Samansky; Andre K. Cizmarik; Anthony Joseph Viola; Ariana Chung-Han; Barbara L. Moore; David Cotta; David G. Conlin; Elham Firouzi Steiner; Gary E Hood; Graham L.W. Day; Jason A. Nagi; Karen M Zelle; Kathleen B. Carr; Keith J. Grady; Kirin K. Gill; Mark Thomas Deming; Matthew J Bresnahan; Matthew R Reed; Michael S Sommer; Peter John Cuomo; Richard Juang; Robyn H Ast; Thomas Hoelder Wintner; Tonia Maria Ouellette Klausner; Tung-On Kong; Wendy Lynn Devine; Zachary Winthrop Silverman | ||
| Firms | Edwards Angell Palmer & Dodge LLP; Edwards Wildman Palmer LLP; Edwards Wildman Palmer, LLP-MA; Locke Lord LLP (NYC); Polsinelli Shughart P.C. (NY); Polsinelli Shughart PC; Wilson Sonsini Goodrich & Rosati (CA); Wilson Sonsini Goodrich & Rosati, P.C.; Wilson Sonsini Goodrich & Rosati, P.C. (San Diego) | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Takeda Pharmaceutical Company Limited v. Mylan, Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Takeda Pharmaceutical Company Limited v. Mylan, Inc. (S.D.N.Y. 2012)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2012-01-03 | 1 | Complaint | United States Patent No. 6,099,859 (“the ‘859 patent”), entitled “Controlled Release Oral Tablet Having a…the ‘859 patent, ‘162 patent, ‘459 patent, ‘866 patent, ‘627 patent, ‘1 16 patent and ‘946 patent (collectively…under the ‘584 patent, the ‘043 patent, and the ‘090 patent (collectively, “Takeda Patents”). 20. United…licensed under the ‘584 patent, ‘043 patent and ‘090 patent (collectively, “Takeda Patents”) in connection with…Venue l. This is an action for patent infringement arising under the patent laws of the United States, Title | External link to document |
| 2012-10-11 | 75 | Memorandum & Opinion | in any event that the 1 United States Patents No. 5,965,584, 6,166,043, 6,172,090, 6,099,859, 6,495,…claims in two patents: the ‘859 and ‘162 Patents. A. The Specifications of the Six Patents Mylan…” The patents proceed to describe this as “limited research.” ‘946 Patent, 1:62-66; ‘627 Patent, 1:59-…appears in the ‘459, ‘866, and ‘162 Patents (‘459 Patent, 3:5-7; ‘866 Patent, 3:3-5; ‘162, 2:16-19). The following…for two of the patents, and in other sections of the specifications for all six patents. The only portion | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
